|Peginterferon α‐2a and ribavirin treatment of patients with haemophilia and hepatitis C virus infection: a single‐centre study of 367 cases|
SM Alavian, SV Tabatabaei, M Keshvari, B Behnava, SM Miri, ...
Liver International 30 (8), 1173-1180, 2010
|Development and validation of a simple, rapid and inexpensive PCR-RFLP method for genotyping of common IL28B polymorphisms: a useful pharmacogenetic tool for prediction of …|
H Sharafi, A Pouryasin, SM Alavian, B Behnava, M Keshvari, ...
Hepatitis monthly 12 (3), 190, 2012
|Distribution of hepatitis C virus genotype in Iranian multiply transfused patients with thalassemia|
SM Alavian, SM Miri, M Keshvari, PK Elizee, B Behnava, SV Tabatabaei, ...
Transfusion 49 (10), 2195-2199, 2009
|Distribution of IL28B genotypes in Iranian patients with chronic hepatitis C and healthy individuals|
H Sharafi, A Pouryasin, SM Alavian, B Behnava, M Keshvari, S Salimi, ...
Hepatitis Monthly 12 (12), 2012
|Economic burden of hepatitis B virus-related diseases: evidence from iran|
K Keshavarz, A Kebriaeezadeh, SM Alavian, AA Sari, FA Dorkoosh, ...
Hepatitis monthly 15 (4), 2015
|Distribution of hepatitis C virus genotypes in iranian patients with congenital bleeding disorders|
M Keshvari, SM Alavian, B Behnava, SM Miri, EP KARIMI, SV Tabatabaei, ...
IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ) 12 (6), 608-614, 2010
|Hepatitis A virus and hepatitis E virus seroprevalence among blood donors in Tehran, Iran|
K Hesamizadeh, H Sharafi, H Keyvani, SM Alavian, ANT Shabankareh, ...
Hepatitis monthly 16 (1), 2016
|Low dose ribavirin for treatment of hepatitis C virus infected thalassemia major patients; new indications for combination therapy|
SV Tabatabaei, SM Alavian, M Keshvari, B Behnava, SM Miri, PK Elizee, ...
Hepatitis monthly 12 (6), 372, 2012
|Predicting response to HBV vaccination in people with positive anti-HBc but negative HBsAg and anti-HBs|
A Kabir, SM Alavian, AH Faghihi Kashani, M Keshvari
Human vaccines 4 (5), 379-383, 2008
|Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients|
A Haj-Sheykholeslami, M Keshvari, H Sharafi, A Pouryasin, K Hemmati, ...
World Journal of Gastroenterology: WJG 21 (29), 8935, 2015
|Modelling influential factors on customer loyalty in public libraries: a study of West Iran|
M Keshvari, FZ Farashbandi, E Geraei
The Electronic Library, 2015
|Prevalence and trends of transfusion-transmitted infections among blood donors in Tehran, Iran from 2008 to 2013|
M Keshvari, H Sharafi, SM Alavian, H Mehrabadi, S Zolfaghari
Transfusion and Apheresis Science 53 (1), 38-47, 2015
|The impact of IFNL4 rs12979860 polymorphism on spontaneous clearance of hepatitis C; a case-control study|
H Sharafi, SM Alavian, B Behnava, A Pouryasin, M Keshvari
Hepatitis monthly 14 (10), 2014
|The role of polymorphisms near the IL28B gene on response to peg-interferon and ribavirin in thalassemic patients with hepatitis C|
B Behnava, H Sharafi, M Keshvari, A Pouryasin, L Mehrnoush, S Salimi, ...
Hepatitis monthly 16 (1), 2016
|Investigating the relative risk factors of injuries caused by accidents on roads in the Mashhad area in 2007|
A Vafaee-Najar, M Khabbazkhoob, H Alidadi-Soltangholi, S Asgari, ...
Iranian Red Crescent Medical Journal 13 (8), 530, 2011
|Update on recommendations for the clinical management of hepatitis C in Iran 2017|
SM Alavian, H Sharafi, M Mirshamsi, A Vazirizadeh, R Omranipour, ...
Hepat Mon 17 (11), e63956, 2017
|Impact of IFNL4 rs12979860 and rs8099917 polymorphisms on response to Peg‐Interferon‐α and Ribavirin in patients with congenital bleeding disorder and …|
M Keshvari, SM Alavian, B Behnava, A Pouryasin, JC Craig, H Sharafi
Journal of clinical laboratory analysis 31 (4), e22063, 2017
|Comparison of Serum Hepatitis B Virus DNA and HBsAg Levels Between HBeAg-Negative and HBeAg-Positive Chronic Hepatitis B Patients|
M Keshvari, SM Alavian, H Sharafi
Jundishapur journal of microbiology 8 (3), 2015
|Efficacy of prolonged treatment with pegylated interferon (Peg-IFN) and ribavirin in thalassemic patients with hepatitis C who relapsed after previous peg-IFN-based therapy|
S Sandoughdaran, SM Alavian, H Sharafi, B Behnava, S Salimi, ...
Hepatitis monthly 15 (1), 2015
|Seroepidemiology and clinical features of hepatitis delta among HBsAg carriers: a study from Hepatitis Clinic of Iranian Blood Transfusion Organization|
M Keshvari, SM Alavian, B Aghaee, B Behnava, M Mahdavi, ...
Transfusion Medicine 24 (6), 411-417, 2014